220 related articles for article (PubMed ID: 30937927)
41. Dosing, Monitoring, Blood Product Utilization, and Thromboembolic Complications of Four-Factor Prothrombin Complex Concentrate as Part of an Institutional Protocol in Pediatric Cardiac Surgery: A Retrospective Cohort Study.
Kiskaddon AL; Goldenberg NA; Fierstein JL; Miller A; Quintessenza JA; Kartha VM
Semin Thromb Hemost; 2023 Dec; ():. PubMed ID: 38049114
[TBL] [Abstract][Full Text] [Related]
42. The association of prothrombin complex concentrates with postoperative outcomes in cardiac surgery: an observational substudy of the FIBRES randomized controlled trial.
Bartoszko J; Callum J; Karkouti K;
Can J Anaesth; 2021 Dec; 68(12):1789-1801. PubMed ID: 34523108
[TBL] [Abstract][Full Text] [Related]
43. Utility of prothrombin complex concentrate as first-line treatment modality of coagulopathy in patients undergoing liver transplantation: A propensity score-matched study.
Srivastava P; Agarwal A; Jha A; Rodricks S; Malik T; Makki K; Singhal A; Vij V
Clin Transplant; 2018 Dec; 32(12):e13435. PubMed ID: 30375084
[TBL] [Abstract][Full Text] [Related]
44. Utilization and safety of off-label prothrombin complex concentrate (four-factor prothrombin complex concentrate) in a surgical population.
Sandquist K; Kaucher K; Newell J; Sarangarm P; Burnett A
Blood Coagul Fibrinolysis; 2024 Apr; 35(3):124-128. PubMed ID: 38477833
[TBL] [Abstract][Full Text] [Related]
45. Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements.
Schaden E; Kimberger O; Kraincuk P; Baron DM; Metnitz PG; Kozek-Langenecker S
Br J Anaesth; 2012 Sep; 109(3):376-81. PubMed ID: 22719014
[TBL] [Abstract][Full Text] [Related]
46. Thromboembolic safety and efficacy of prothrombin complex concentrates in the emergency reversal of warfarin coagulopathy.
Majeed A; Eelde A; Agren A; Schulman S; Holmström M
Thromb Res; 2012 Feb; 129(2):146-51. PubMed ID: 21807399
[TBL] [Abstract][Full Text] [Related]
47. Four-factor prothrombin complex concentrate to reduce allogenic blood product transfusion in patients with major trauma, the PROCOAG trial: study protocol for a randomized multicenter double-blind superiority study.
Bouzat P; Bosson JL; David JS; Riou B; Duranteau J; Payen JF;
Trials; 2021 Sep; 22(1):634. PubMed ID: 34530886
[TBL] [Abstract][Full Text] [Related]
48. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
[TBL] [Abstract][Full Text] [Related]
49. Hemostatic Therapy Using Tranexamic Acid and Coagulation Factor Concentrates in a Model of Traumatic Liver Injury.
Zentai C; van der Meijden PE; Braunschweig T; Hueck N; Honickel M; Spronk HM; Rossaint R; Grottke O
Anesth Analg; 2016 Jul; 123(1):38-48. PubMed ID: 27192476
[TBL] [Abstract][Full Text] [Related]
50. Impact of Prothrombin Complex Concentrate on Blood Use, Cost, and Outcomes in Heart Transplantation.
Wu DW; Xia Y; Uelinger J; Forest S; Szymanski J; Mohandas K; Walsh R; Karim S; Marks E; Himchak E; Gupta R; Goldstein D
Ann Thorac Surg; 2018 Apr; 105(4):1152-1157. PubMed ID: 29397934
[TBL] [Abstract][Full Text] [Related]
51. Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery.
Cappabianca G; Mariscalco G; Biancari F; Maselli D; Papesso F; Cottini M; Crosta S; Banescu S; Ahmed AB; Beghi C
Crit Care; 2016 Jan; 20():5. PubMed ID: 26738468
[TBL] [Abstract][Full Text] [Related]
52. Comparative effectiveness of 3- versus 4-factor prothrombin complex concentrate for emergent warfarin reversal.
Voils SA; Holder MC; Premraj S; Catlin JR; Allen BR
Thromb Res; 2015 Sep; 136(3):595-8. PubMed ID: 26233569
[TBL] [Abstract][Full Text] [Related]
53. Is there a difference in efficacy, safety, and cost-effectiveness between 3-factor and 4-factor prothrombin complex concentrates among trauma patients on oral anticoagulants?
Mangram A; Oguntodu OF; Dzandu JK; Hollingworth AK; Hall S; Cung C; Rodriguez J; Yusupov I; Barletta JF
J Crit Care; 2016 Jun; 33():252-6. PubMed ID: 27021851
[TBL] [Abstract][Full Text] [Related]
54. Retrospective Comparison of Recombinant Activated Factor VII Versus 4-Factor Prothrombin Complex Concentrate in Cardiac Surgical Patients.
Faraoni D; Guindi A; Ankola AA; Resheidat A; Binsalamah Z; Teruya J; Savorgnan F; Vener DF
J Cardiothorac Vasc Anesth; 2024 Feb; 38(2):388-393. PubMed ID: 38129208
[TBL] [Abstract][Full Text] [Related]
55. Safety of Prothombin Complex Concentrate to Control Excess Bleeding During Continuous Flow LVAD Insertion.
Bradford CD; Stahovich MJ; Dembitsky WP; Adamson RM; Engelbert JJ; Perreiter AS
ASAIO J; 2015; 61(5):509-13. PubMed ID: 26102176
[TBL] [Abstract][Full Text] [Related]
56. Edoxaban effects on bleeding following punch biopsy and reversal by a 4-factor prothrombin complex concentrate.
Zahir H; Brown KS; Vandell AG; Desai M; Maa JF; Dishy V; Lomeli B; Feussner A; Feng W; He L; Grosso MA; Lanz HJ; Antman EM
Circulation; 2015 Jan; 131(1):82-90. PubMed ID: 25403645
[TBL] [Abstract][Full Text] [Related]
57. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
[TBL] [Abstract][Full Text] [Related]
58. A pragmatic pilot phase II randomised controlled trial of prothrombin complex concentrates (PCC) versus fresh frozen plasma (FFP) in adult patients who are undergoing heart surgery (PROPHESY).
Green L; Roberts N; Cooper J; Field J; Gill R; Klein A; Agarwal S; Stanworth S; Johnston A; Monk V; O'Brien B
Trials; 2019 Dec; 20(1):684. PubMed ID: 31815658
[TBL] [Abstract][Full Text] [Related]
59. Haemostatic therapy in coronary artery bypass graft patients with decreased platelet function: comparison of fibrinogen concentrate with allogeneic blood products.
Solomon C; Schöchl H; Hanke A; Calatzis A; Hagl C; Tanaka K; Rahe-Meyer N
Scand J Clin Lab Invest; 2012 Apr; 72(2):121-8. PubMed ID: 22233480
[TBL] [Abstract][Full Text] [Related]
60. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.
Ranucci M; Baryshnikova E; Crapelli GB; Rahe-Meyer N; Menicanti L; Frigiola A;
J Am Heart Assoc; 2015 Jun; 4(6):e002066. PubMed ID: 26037084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
